RNA – avidity biosciences, inc. (US:NASDAQ)
Stock Stats
News
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $33.00 price target on the stock.
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $35.00 price target on the stock.
Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights [Yahoo! Finance]
Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
Avidity Biosciences to Participate in Upcoming Investor Conference [Yahoo! Finance]
Form 144 Avidity Biosciences, Filed by: MacLean Michael F
Form S-3ASR Avidity Biosciences,
Form 10-Q Avidity Biosciences, For: Mar 31
Form 8-K Avidity Biosciences, For: May 09
Form 4 Avidity Biosciences, For: May 07 Filed by: Boyce Sarah
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.